J.A. Lockton

Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: A randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial

R.A. Hannon, Glen Clack, Martin Rimmer et al. · Journal of Bone and Mineral Research · 2009 · 110 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Insulin resistance, diabetes, and risk markers for ischaemic heart disease in Asian men and non-Asian in Bradford.

Taylor Knight, Z. Smith, A Whittles et al. · Heart · 1992 · 89 citations · Full text

Medicine, Endocrinology, Health Sciences +15

Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index

Toralph Ruge, J.A. Lockton, Frida Renström et al. · Metabolism · 2009 · 84 citations

Medicine, Endocrinology, Physiology +8

Pharmacokinetic and pharmacodynamic assessment of a five‐probe metabolic cocktail for CYPs 1A2, 3A4, 2C9, 2D6 and 2E1

Graham Blakey, J.A. Lockton, John Perrett et al. · British Journal of Clinical Pharmacology · 2003 · 65 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

A comparative study of the effects of carbamazepine and the NMDA receptor antagonist remacemide on road tracking and car-following performance in actual traffic

Johannes G. Ramaekers, C. Lamers, Frans R.J. Verhey et al. · Psychopharmacology · 2001 · 41 citations

Medicine, Pharmacology, Neuropharmacology +11